Lonza  
Careers @ Lonza | Contact us | Sitemap |
Shop
 
Home > Company > Media Center > News Archive > 2003 > Proposal Board
 
Proposal Board of Directors
send     print    

Lonza Group will propose Sir Richard Sykes as a member of its Board of Directors



Media Releases Financial Reports Presen-tations
02/25/2003      
Lonza Group will propose Sir Richard Sykes as a member of its Board of Directors


The Board of Directors of Lonza Group is pleased to announce that it will propose the addition of Sir Richard Sykes as a director of the company at its next Annual Shareholders' meeting on 26 March 2003.


Sir Richard Sykes (61), currently Rector of Imperial College of Science, Technology and Medicine, was Chairman of GlaxoSmithKline plc until May 2002, and its Chief Executive until October 1997. Sir Richard Sykes brings with him some 30 years of experience in the pharmaceutical and biotechnology industries acquired since being awarded a PhD in Microbial Biochemistry from Bristol University and a DSc from the University of London.

"I am delighted that Sir Richard Sykes has accepted to join us on the Board of Lonza" stated Sergio Marchionne, Chairman of the Board of Lonza Group Ltd. "His contributions will substantially strengthen our Board in guiding and supporting the executive leadership in the implementation of its life sciences objectives" added Marchionne.

All current members of the Board of Directors will stand for re-election.

As previously announced, Mr. Peter Matter will also be proposed for election at the next shareholders' meeting.

Lonza Group is a Life Sciences driven company headquartered in Switzerland, with sales of CHF 2.54 billion in 2002 and operating 18 production and R&D facilities in 8 countries. It employs 6200 people worldwide and is the leading custom manufacturer of active chemical ingredients, intermediates and biotechnology solutions to the pharmaceutical and agrochemical industries. It also offers organic intermediates for a wide range of applications and provides antimicrobial and associated products as well as polymer intermediates and compounds. For more information on Lonza Group please visit the company's website at www.lonza.com.

For further information please contact:
Walter Eschenmoser
Communications & Investor Relations
Tel +41 61 316 8363
Fax +41 61 361 8220
walter.eschenmoser@lonza.com


Disclaimer